Merck : MRK

All Merck Articles

1087 Articles

Jon C. Ogg | Aug 3, 2020 at 9:18 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm,…

Chris Lange | Jul 31, 2020 at 11:18 AM EDT

Keytruda, COVID-19 Hopes Prompt Merck Earnings Beat, Rosy Outlook

When Merck & Co. (NYSE: MRK | MRK Price Prediction) reported its second-quarter financial results before the markets opened on…

Chris Lange | Jul 26, 2020 at 6:33 AM EDT

Apple, Boeing, Exxon, McDonald’s, Visa and More Dow Earnings This Week

24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week,…

Chris Lange | May 26, 2020 at 10:37 AM EDT

Meet Merck’s Newest Collaborations in the Fight Against COVID-19

Merck shares jumped on Tuesday after the company announced that it has made deals to develop drugs in the fight…

Chris Lange | Apr 28, 2020 at 1:17 PM EDT

Why Pfizer and Merck Earnings Are Slowing the Dow

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering,…

Chris Lange | Apr 27, 2020 at 12:13 PM EDT

What to Watch When Merck and Pfizer Report Tuesday Morning

Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.

Chris Lange | Apr 27, 2020 at 9:37 AM EDT

Big Pharma Short Sellers Can’t Make Up Their Minds

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 26, 2020 at 7:20 AM EDT

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

Over one-third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Here's…

Chris Lange | Apr 13, 2020 at 9:58 AM EDT

Big Pharma Short Sellers Focus on a Couple of Favorites

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Mar 16, 2020 at 1:32 PM EDT

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

24/7 Wall St. wanted to see which companies have the best chance at not having to lower their dividends at…

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Chris Lange | Feb 27, 2020 at 8:45 AM EST

Big Pharma Scares Off Short Sellers

The February 14 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 20, 2020 at 7:35 AM EST

15 Top ESG Stocks That Look Undervalued for 2020

With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks…

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

1 … 12 13 14 15 16 … 73

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

Keytruda, COVID-19 Hopes Prompt Merck Earnings Beat, Rosy Outlook

Apple, Boeing, Exxon, McDonald’s, Visa and More Dow Earnings This Week

Meet Merck’s Newest Collaborations in the Fight Against COVID-19

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

Big Pharma Short Sellers Focus on a Couple of Favorites

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

Short Sellers Run for Cover From Big Pharma Stocks

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

‘Over My Dead Body’: Suze Orman to a Listener Who Wanted to Pay Off His Dying Father-in-Law’s $50,000 in Credit Card Debt

‘Good for You. Way to Go’: Dave Ramsey to a 74-Year-Old Lawyer Who Cleared $900,000 on a Property Sale but Has No Retirement Plan

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

Keytruda, COVID-19 Hopes Prompt Merck Earnings Beat, Rosy Outlook

Apple, Boeing, Exxon, McDonald’s, Visa and More Dow Earnings This Week

Meet Merck’s Newest Collaborations in the Fight Against COVID-19

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

Big Pharma Short Sellers Focus on a Couple of Favorites

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

Short Sellers Run for Cover From Big Pharma Stocks

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

‘Over My Dead Body’: Suze Orman to a Listener Who Wanted to Pay Off His Dying Father-in-Law’s $50,000 in Credit Card Debt

‘Good for You. Way to Go’: Dave Ramsey to a 74-Year-Old Lawyer Who Cleared $900,000 on a Property Sale but Has No Retirement Plan

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line